Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial.

Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial. Arch Cardiovasc Dis. 2009 Jun-Jul; 102(6-7):485-96.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.